Catalent
CTLT
#1813
Rank
โ‚น1.055 T
Marketcap
โ‚น5,817
Share price
0.00%
Change (1 day)
20.47%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น580.09. In 2023 the company made an earnings per share (EPS) of -โ‚น623.16 a decrease over its 2022 EPS that were of โ‚น208.03.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-15.41%
2023-โ‚น623.16-399.56%
2022โ‚น208.03-30.58%
2021โ‚น299.6779.67%
2020โ‚น166.79114.12%
2019โ‚น77.89-15%
2018โ‚น91.6475.44%
2017โ‚น52.24-22.97%
2016โ‚น67.81-59.56%
2015โ‚น167.70282.05%
2014โ‚น43.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น30.24-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-โ‚น546.18-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น68.73-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น135.63-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA